Kenji Momose
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Mosapride as a Pre-Endoscopy Preparation in a Patient Receiving GLP-1 Receptor Agonist Therapy.
Journal: Internal medicine (Tokyo, Japan)
Published: April 01, 2026
Severe Immune Checkpoint Inhibitor-associated Gastritis Treated with Steroids and Infliximab.
Journal: Internal medicine (Tokyo, Japan)
Published: September 18, 2025
Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 11, 2025
Higher Absolute Lymphocyte Counts and Lower Des-γ-Carboxyprothrombin Levels After Treatment Initiation Are Associated With the Clinical Efficacy of Tremelimumab Plus Durvalumab Combination Therapy for Hepatocellular Carcinoma.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: December 03, 2024
Efficacy and safety of elobixibat in combination with or switched from conventional treatments of chronic constipation: A retrospective observational study.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: April 24, 2024
Current Status of Conversion Hepatectomy After Sorafenib and Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
Journal: Anticancer research
Published: April 08, 2024
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: March 05, 2023
Significance of post-progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: February 14, 2022
Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
Journal: Digestive diseases (Basel, Switzerland)
Published: August 12, 2020
Propensity score matching analysis: incidence and risk factors for "stardust" gastric mucosa, a novel gastric finding potentially induced by vonoprazan.
Journal: Alimentary pharmacology & therapeutics
Published: July 31, 2020
A rare case of pyogenic granuloma of the jejunum causing gastrointestinal bleeding.
Journal: Clinical journal of gastroenterology
Published: April 21, 2020
Risk Factors for Adverse Events in Patients with Chronic Constipation Following Lubiprostone Administration.
Journal: Digestive diseases (Basel, Switzerland)
Published: November 02, 2019
Last Updated: 09/26/2026